• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性胰腺血管活性肠肽瘤:临床病程恶化及肝移植成功治疗

Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.

作者信息

Hengst K, Nashan B, Avenhaus W, Ullerich H, Schlitt H J, Flemming P, Pichlmayr R, Domschke W

机构信息

Department of Medicine B, University of Münster, Germany.

出版信息

Z Gastroenterol. 1998 Mar;36(3):239-45.

PMID:9577908
Abstract

Gastrointestinal neuroendocrine tumors are slowly growing and metastases are often limited to the liver. As a result of their favorable biological behavior these tumors have a relatively good prognosis even in metastatic stage. Due to a variety of therapeutic options patients with malignant neuroendocrine tumors may survive for extended periods of time up to ten years. Often a combination of different treatments and also alternation between the different therapeutic regimes is needed. A patient with excessive WDHA-syndrome and severe metabolic disturbances due to a pancreatic VIPoma with metastatic spread into the liver and abundant hormonal secretion is presented. Cytotoxic agents (streptozocin, 5-fluorouracil and adriamycin) were able to alleviate clinical symptoms and to control tumor growth for six years. Analogues of somatostatin (octreotide) and interferon alpha had been very useful in controlling clinical symptoms and tumor progress for 18 months. Cytotoxic agents or octreotide were not able, however, to achieve any permanent cure. Eventually, treatment failure occurred with dramatic progression of symptoms and tumor growth, unresponsive to any medical therapy. Consequently, total hepatectomy and liver transplantation together with extirpation of the pancreatic primary tumor was performed and succeeded in providing a normal life to the patient. In our opinion the overall outcome of patients with metastatic VIPoma may be improved best by maintaining the patients on medical therapy until treatment failure occurs. In case of extended hepatic metastases orthotopic liver transplantation might be considered for patients with symptomatic disease who no longer respond to conventional treatment modalities.

摘要

胃肠道神经内分泌肿瘤生长缓慢,转移通常局限于肝脏。由于其良好的生物学行为,这些肿瘤即使在转移阶段预后也相对较好。由于有多种治疗选择,恶性神经内分泌肿瘤患者可能存活很长时间,长达十年。通常需要联合不同的治疗方法,并且在不同的治疗方案之间交替使用。本文介绍了一名因胰腺血管活性肠肽瘤(VIPoma)导致严重水样腹泻伴低钾血症综合征(WDHA综合征)和严重代谢紊乱、肿瘤转移至肝脏且激素分泌丰富的患者。细胞毒性药物(链脲霉素、5-氟尿嘧啶和阿霉素)能够缓解临床症状并控制肿瘤生长达六年。生长抑素类似物(奥曲肽)和α干扰素在控制临床症状和肿瘤进展方面也发挥了18个月的良好作用。然而,细胞毒性药物或奥曲肽均未能实现永久性治愈。最终,治疗失败,症状和肿瘤生长急剧进展,对任何药物治疗均无反应。因此,实施了全肝切除术和肝移植,并切除了胰腺原发肿瘤,成功使患者恢复正常生活。我们认为,对于转移性VIPoma患者,最好的总体治疗结果是在治疗失败前持续给予药物治疗。对于有症状且对传统治疗方式不再有反应的广泛肝转移患者,可考虑进行原位肝移植。

相似文献

1
Metastatic pancreatic VIPoma: deteriorating clinical course and successful treatment by liver transplantation.转移性胰腺血管活性肠肽瘤:临床病程恶化及肝移植成功治疗
Z Gastroenterol. 1998 Mar;36(3):239-45.
2
Treatment of metastatic Vipoma by liver transplantation.肝移植治疗转移性血管活性肠肽瘤
Clin Transplant. 1990 Oct;4(5 part 1):276-8; discussion 279.
3
VIPoma syndrome: challenges in management.血管活性肠肽瘤综合征:管理难题。
Singapore Med J. 2010 Jul;51(7):e129-32.
4
[Long-term therapy of a metastasizing pancreatic vipoma using the somatostatin derivative octreotide].[使用生长抑素衍生物奥曲肽对转移性胰腺血管活性肠肽瘤进行长期治疗]
Schweiz Med Wochenschr. 1992 Aug 15;122(33):1221-3.
5
Neuroendocrine tumors of the pancreas, excluding gastrinoma.胰腺神经内分泌肿瘤,不包括胃泌素瘤。
Surg Oncol Clin N Am. 2006 Jul;15(3):497-510. doi: 10.1016/j.soc.2006.05.012.
6
Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.长效奥曲肽治疗进展期转移性胃泌素瘤患者抗肿瘤疗效的前瞻性研究
Cancer. 2002 Jan 15;94(2):331-43. doi: 10.1002/cncr.10195.
7
The surgical and systemic management of neuroendocrine tumors of the pancreas.胰腺神经内分泌肿瘤的外科及综合治疗
Surg Clin North Am. 2009 Feb;89(1):249-66, x. doi: 10.1016/j.suc.2008.10.001.
8
Metastatic vipoma arising from colonic primary tumour.源自结肠原发性肿瘤的转移性血管活性肠肽瘤
Eur J Surg Oncol. 1989 Aug;15(4):386-9.
9
A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors.
J Am Coll Surg. 1995 Feb;180(2):184-7.
10
[Metastatic malignant vipoma of the pancreas].[胰腺转移性恶性血管活性肠肽瘤]
Pathologe. 1993 Dec;14(6):381-5.

引用本文的文献

1
Pancreatic VIPomas: subject review and one institutional experience.胰腺血管活性肠肽瘤:病例回顾及单机构经验
J Gastrointest Surg. 2008 Feb;12(2):382-93. doi: 10.1007/s11605-007-0177-0.